Merck, Glenmark Settle Zetia Antitrust Litigation for $70M, Including $23M in Attorney Fees
U.S. District Senior Judge Rebecca Beach Smith of the Eastern District of Virginia approved the final settlement agreement between a class of drug purchasers and pharmaceutical companies, Merck & Co., and Glenmark Pharmaceuticals, which also requires the defendants to pay one-third of the settlement fund in attorney fees, or $23 million, as well as $3.9 million in costs—as requested by plaintiffs' counsel.
October 20, 2023 at 03:25 PM
4 minute read
AntitrustA federal judge in Virginia approved a $70 million settlement agreement Thursday between drug purchasers and two pharmaceutical companies over the cholesterol-lowering medication Zetia, and allegations that drug manufacturers delayed the introduction of a less-expensive generic version.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 2First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 3The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 4The Growing Tension—And Opportunity—in Big Law Nonequity Tiers
- 5The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250